General Genomics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.77M
- Investors
-
4
General Genomics General Information
Description
Operator of an artificial intelligence (AI) and bioinformatics services business intended to support data-driven decision making across public sector and commercial domains. The company offers AI and machine learning-driven analytics, synthetic and de-identified data capabilities, and workflow automation tools, enabling government agencies, researchers, healthcare organizations, and commercial enterprises to extract reliable insights from complex biological and operational data with improved trust, compliance, and efficiency.
Contact Information
Website
www.ggenomics.comCorporate Office
- 309 North West 13th Street
- Suite 103
- Oklahoma City, OK 73103
- United States
Corporate Office
- 309 North West 13th Street
- Suite 103
- Oklahoma City, OK 73103
- United States
General Genomics Timeline
General Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 27-Jan-2026 | $2.77M | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | 15-Nov-2024 | Completed | Generating Revenue | |||
| 2. Equity Crowdfunding | 01-Jun-2021 | $26.4K | $952K | Completed | Generating Revenue | |
| 1. Seed Round | 10-Dec-2020 | $926K | $926K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
General Genomics Comparisons
Industry
Financing
Details
General Genomics Competitors (2)
One of General Genomics’s 2 competitors is Myriad Genetics, a Corporation company based in Salt Lake City, UT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Myriad Genetics | Corporation | Salt Lake City, UT | ||||
| Ancestry | Private Equity-Backed | Draper, UT |
General Genomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
General Genomics Patents
General Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220020503-A1 | Predicting efficacy of preventative measures to mitigate spread of a pathogen and illnesses caused therefrom using machine learning models | Pending | 20-Jul-2020 | ||
| WO-2022019964-A1 | Predicting efficacy of preventative measures to mitigate spread of a pathogen and illnesses caused therefrom using machine learning models | Inactive | 20-Jul-2020 | ||
| US-12070338-B2 | Predicting susceptibility of living organisms to medical conditions using machine learning models | Active | 06-Apr-2020 | ||
| US-20210307700-A1 | Predicting susceptibility of living organisms to medical conditions using machine learning models | Active | 06-Apr-2020 | ||
| US-20210307701-A1 | Predicting susceptibility of living organisms to medical conditions using machine learning models | Inactive | 06-Apr-2020 | A61B5/7275 |
General Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
General Genomics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| USC Education Technology Accelerator | Accelerator/Incubator | |||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority |
General Genomics Investments (1)
General Genomics’s most recent deal was a Joint Venture with Shield Score. The deal was made on 01-Jun-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Shield Score | 01-Jun-2020 | Joint Venture | Business/Productivity Software |
General Genomics FAQs
-
When was General Genomics founded?
General Genomics was founded in 2020.
-
Where is General Genomics headquartered?
General Genomics is headquartered in Oklahoma City, OK.
-
What is the size of General Genomics?
General Genomics has 16 total employees.
-
What industry is General Genomics in?
General Genomics’s primary industry is Security Services (B2B).
-
Is General Genomics a private or public company?
General Genomics is a Private company.
-
What is General Genomics’s current revenue?
The current revenue for General Genomics is .
-
How much funding has General Genomics raised over time?
General Genomics has raised $3.73M.
-
Who are General Genomics’s investors?
USC Education Technology Accelerator, , , and have invested in General Genomics.
-
Who are General Genomics’s competitors?
Myriad Genetics and Ancestry are competitors of General Genomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
